跳至主要内容
临床试验/IRCT138807062513N1
IRCT138807062513N1已完成未知

Effect of Brewers yeast on glycosylated hemoglobin, insulin resistance, insulin sensitivity and blood pressure in patients with type 2 diabetes mellitus

Tehran University of Medical Science0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 55 years(—)
性别
All

入选标准

  • History of at least 2 years clinically diagnosed type 2 diabetes mellitus; taking oral hypoglycemic drugs ; Fasting blood glucose at least more than 125 mg/dl; Not consuming brewers yeast during the last 3 months; Aged 35-55 years; Signing the informed consent form (attached). Exclusion criteria: History of hepatitis, cardiovascular, renal and Parkinson's diseases, gout and depression disorder, A record of angina pectoris, myocardial and cerebral infarction during the last year; History of infectious disease or common cold during the last 4 weeks; Regular consumption of anti-inflammatory drugs (steroid or non-steroid) or monoamine oxidase inhibitors; Insulin therapy; Consumption of brewers yeast or placebo less than 12 weeks; Any side effects due to supplementation; Change in diet or hypoglycemic drugs; Unwilling to continue taking supplementation.

排除标准

  • 未提供

研究者

发起方
Tehran University of Medical Science

相似试验